நிறுவனம் எங்களுக்கு கட்டம் இப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் எங்களுக்கு கட்டம் இப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் எங்களுக்கு கட்டம் இப் Today - Breaking & Trending Today

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results

Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results
Helix or the
Company ), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced its fiscal 2021 first quarter results for the period ending October 31, 2020.
OVERVIEW
The Company reported a net loss and total comprehensive loss of $222,000 for the three-month period ended October 31, 2020 (2019 - $2,214,000). Net loss and comprehensive loss for the three-month period ending October 31, 2020 included a gain from loss of control in Helix Immuno-Oncology S.A. ( HIO ) of $2,162,000 (2019 - $nil) on September 3, 2020.
On November 9, 2020, the Company announced that it has signed a definitive share purchase agreement with CAIAC Fund Management AG ( CAIAC ) to purchase the Company s remaining 29.89% holdings in Helix Immuno-Oncology S.A. ( HIO ), for gross proce ....

Richmond Hill , Pascal Nigen , Company Us Phase Ib , Moffit Cancer Center , Drug Administration , Helix Biopharma Corp , Fund Management , Alpha Bronze , Toronto Stock Exchange , Company Statement Of Financial Position , Helix Biopharma , Management Est , European Phase , Moffit Cancer , Consulting Management , Financial Position , Net Loss , Comprehensive Loss , Looking Statements , Annual Information Form , ரிச்மண்ட் மலை , பாஸ்கல் நீகெண் , நிறுவனம் எங்களுக்கு கட்டம் இப் , மோப்பித் புற்றுநோய் மையம் , நிதி மேலாண்மை , ஆல்பா வெண்கலம் ,

Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results

Forward-Looking Statements and Risks and Uncertainties
This news release contains forward-looking statements and information (collectively, forward-looking statements ) within the meaning of applicable Canadian securities laws. Forward-looking statements are statements and information that are not historical facts but instead include financial projections and estimates, statements regarding plans, goals, objectives, intentions and expectations with respect to the Company s future business, operations, research and development, including the Company s activities relating to DOS47, and other information in future periods.
Forward-looking statements include, without limitation, statements concerning (i) the Company s ability to operate on a going concern being dependent mainly on obtaining additional financing; (ii) the Company s priority continuing to be L-DOS47; (iii) the Company s development programs for DOS47, L-DOS47, V-DOS47 and CAR-T; (iv) future expenditures, the in ....

Richmond Hill , Pascal Nigen , Company Us Phase Ib , Moffit Cancer Center , Drug Administration , Helix Biopharma Corp , Fund Management , Alpha Bronze , Toronto Stock Exchange , Company Statement Of Financial Position , Helix Biopharma , Management Est , European Phase , Moffit Cancer , Consulting Management , Financial Position , Net Loss , Comprehensive Loss , Looking Statements , Annual Information Form , ரிச்மண்ட் மலை , பாஸ்கல் நீகெண் , நிறுவனம் எங்களுக்கு கட்டம் இப் , மோப்பித் புற்றுநோய் மையம் , நிதி மேலாண்மை , ஆல்பா வெண்கலம் ,